These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4313170)

  • 21. [Study on the sensibility "in vitro" to antibiotics of 77 strains of "Pseudomonas aeruginosa" (author's transl)].
    Padovani F; Pilotti C
    Ann Sclavo; 1976; 18(5):749-54. PubMed ID: 829305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of polymyxins in combination with β-lactams against clinical strains of Pseudomonas aeruginosa.
    Mitsugui CS; Tognim MC; Cardoso CL; Carrara-Marroni FE; Botelho Garcia L
    Int J Antimicrob Agents; 2011 Nov; 38(5):447-50. PubMed ID: 21872449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serotype and antibiotic sensitivity of Pseudomonas aeruginosa isolated from clinical materials].
    Yoshioka H; Takimoto M; Maruyama S; Furuyama M; Murayama T
    Kansenshogaku Zasshi; 1970 Sep; 44(6):340-4. PubMed ID: 4319797
    [No Abstract]   [Full Text] [Related]  

  • 24. Synergistic combinations of polymyxins.
    Lenhard JR; Nation RL; Tsuji BT
    Int J Antimicrob Agents; 2016 Dec; 48(6):607-613. PubMed ID: 27865626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effectiveness of various disinfection methods on the surface of gloved hands].
    Göktaş P; Oktay G; Ozel A
    Mikrobiyol Bul; 1992 Jul; 26(3):271-80. PubMed ID: 1528148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
    J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the problem of efficient antibiotic therapy of infections caused by Pseudomonas aeruginosa.
    Vacek V; Wagnerová M
    Chemotherapy; 1969; 14(5):308-21. PubMed ID: 4311865
    [No Abstract]   [Full Text] [Related]  

  • 28. Synergism between chlorhexidine and polymyxins against Pseudomonas aeruginosa.
    Al-Najjar AR; Quesnel LB
    J Appl Bacteriol; 1979 Dec; 47(3):469-76. PubMed ID: 232100
    [No Abstract]   [Full Text] [Related]  

  • 29. Indole and (E)-2-hexenal, phytochemical potentiators of polymyxins against Pseudomonas aeruginosa and Escherichia coli.
    Kubo A; Lunde CS; Kubo I
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1438-41. PubMed ID: 8726016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the germicidal activity of prepodyne and betadine surgical scrub solutions.
    Kilpatrick L; Knight RA
    Am J Med Technol; 1975 May; 41(5):180-4. PubMed ID: 805538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyocin sensitivity of pseudomonas aeruginosa pretreated with antibiotics.
    Stevens GS; Ottolenghi AC
    Can J Microbiol; 1977 May; 23(5):583-8. PubMed ID: 194663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility of recent isolates of Pseudomonas aeruginosa to gentamicin, polymyxin, and five penicillins, with observations on the pyocin and immunotypes of the strains.
    Adler JL; Finland M
    Appl Microbiol; 1971 Nov; 22(5):870-5. PubMed ID: 4332044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Isolation rate of Pseudomonas aeruginosa from clinical materials and its susceptibility to antibiotics].
    Oguri T; Kosakai N
    Jpn J Antibiot; 1971 Jun; 24(3):121-5. PubMed ID: 4327335
    [No Abstract]   [Full Text] [Related]  

  • 34. [Susceptibility of pathogens isolated from clinical specimens to lividomycin].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1972 Dec; 25(6):343-6. PubMed ID: 4353339
    [No Abstract]   [Full Text] [Related]  

  • 35. Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods.
    Jones RN; Anderegg TR; Swenson JM;
    J Clin Microbiol; 2005 Feb; 43(2):925-7. PubMed ID: 15695708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bactericidal and synergistic activity of moxalactam alone and in combination with gentamicin against Pseudomonas aeruginosa.
    Yu PK; Edson RS; Washington JA; Hermans PE
    Antimicrob Agents Chemother; 1983 Jan; 23(1):179-81. PubMed ID: 6219619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro sensitivity of isolates of Pseudomonas aeruginosa to carbenicillin, gentamicin, tobramycin, and some other antibiotics.
    Wretland B; Nord CE; Wadström T
    Scand J Infect Dis; 1974; 6(1):49-52. PubMed ID: 4208204
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacokinetics of antimicrobial agents. Lividomycin].
    Fukaya K; Kitamoto O
    Jpn J Antibiot; 1972 Dec; 25(6):375-9. PubMed ID: 4353341
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of two standardized disk methods for testing antimicrobial susceptibility of Pseudomonas aeruginosa and of the Enterobacteriaceae.
    Barry AL; Effinger LJ
    Antimicrob Agents Chemother; 1974 Oct; 6(4):452-9. PubMed ID: 4157344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of inhibitory activity of colistin on Pseudomonas aeruginosa by sulphamethoxazole and sulphamethizole.
    Simmons NA
    Br Med J; 1969 Sep; 3(5672):693-6. PubMed ID: 4980194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.